2013 OncPrac Summit: Corey Langer on managing NSCLC
Which lung cancer patients are eligible for bevacizumab therapy? What about maintenance therapy in this population? What's the latest on erlotinib therapy for EGFR-mutated patients? Find the answers t...
Author: feeds
Added: 04/22/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Avastin | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Tarceva